TwitterLinkedin

Contact Us

  • Biopharma Excellence
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical
          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Integrated Product Development
            • Market Access
            • Scientific Advice
            • Statistics and Data Sciences
            • Toxicology Services
    • Clinical Development
          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Scientific Advice
            • Statistics and Data Sciences
          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations
          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting
          • Quality

            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
    • Authorization / Approval
          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistics and Data Sciences
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance
          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • ICSR (Individual Safety Case Report) Management
            • Literature Monitoring & Screening
            • Pharmacovigilance Quality & Compliance
            • Signal Management
          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
          • Medical Affairs

            • Healthcare Compliance and Medical Approval
    • Program Management
          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise
          • Industry Expertise

            • Biopharmaceuticals
            • MedTech Services
          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • COVID-19 Support
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Post-Brexit Regulatory Support
            • Statistics and Data Sciences
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Career Opportunities
  • Training
Home > SMARTPHLEX > SMART MDR Teaser Tool

SMARTMDRSMART MDR TEASER TOOL

Are you ready for the new EU Medical Device Regulation? Our team of Medical Device experts has developed a highly effective tool that can be used to assess a complete MDR readiness of all your products.

To gain an indication of your readiness, take our survey below. Complete five questions and get an understanding of your readiness and determine your state of compliance. Your answers will give you a flavor of how our suite of SMARTCHECK MDR services will help you to transition and continue commercializing your products.  Results are shown in an easy traffic light appearance and explained accordingly.

If you have any questions, please reach us at contact@pharmalex.com.

To find out how PharmaLex can support your EUMDR readiness

CONTACT US

1Have the identified Economic Operators been added to the list of approved suppliers and any audit requirements identified?

2Are the professional qualifications and experience of the Person Responsible for Regulatory Compliance (PRRC) recorded and available for review?

3Is there a robust system to record sales volumes and / or frequencies of device use so that the Periodic Safety Update Reports (PSUR) can be prepared?

4Are you prepared for unannounced inspections of your sites and those of your economic operators by the a Competent Authority as well as your Notified Body (NB)?

5Have you agreed the timetable for review of the revised MDR Technical Documentation with your NB?

On the basis of this sample of questions, you are progressing well toward being compliant. If you would like to see how PharmaLex can deploy the full SMARTMDR engine, please reach out to contact@pharmalex.com to see how we can help.
Print

On the basis of this small sample of questions, there may be some gaps remaining in your compliance and we recommend that you seek further advice. PharmaLex can assist you by deploying the full SMARTMDR engine to give you a more complete picture of what needs to be done to remain compliant on your Medical Device Regulatory journey. Please reach out to contact@pharmalex.com to see how we can help.
Print

On the basis of this small sample of questions, we strongly recommend you take immediate actions to continue commercializing your products under a monitored process. PharmaLex can assist you by deploying the full SMARTMDR engine to give you a more complete picture of what needs to be done to remain compliant. Please reach out to contact@pharmalex.com to see how we can help.
Print

Contact PharmaLex for help to ensure you are EUMDR compliant

CONTACT US
Hands,Of,Young,Woman,Sending,Text,Message,From,Smart,Phone

Digital Health

Are you developing health-related software or smart apps? Do you know if your software or app will be classified as a medical device? And is your product ready to meet the requirements of the new EU Medical Device Regulation (MDR) effective in May 2021? Complete our short questionnaire to learn more and find out what help you will need.

Related News

Medical device software brings new complications around compliance
Medical device software brings new complications around compliance
30th May 2022
Navigating the impact of the IVDR on marketed products
Navigating the impact of the IVDR on marketed products
24th March 2022
Next Steps for EUDAMED implementation within MDR
Next Steps for EUDAMED implementation within MDR
7th March 2022

Related Resources

Fact Flyers

  • Medical Device Regulations Transition Support
  • Medical Devices for the Pharmaceutical Industry
  • Medical Device Services

Case Studies

  • PharmaLex keeps medical device CE marking on track

White Papers

  • QMS aspects of the Medical Device Regulation
  • The medical device regulations and their implications on device vigilance
  • In Vitro Diagnostic Medical Devices Regulation – Summary of changes and impact for manufacturers
  • Medical Device Software and Mobile Apps
  • Navigating the regulatory submission process for a class III medical device with ancillary medicine
  • The Medical Device Regulation – Readiness for May 2021
  • Software, AI and Medical Devices - What's Up?

Webinars

  • Get Your Design in Control
  • Medical Device Risk Management for Patient and Product Safety
  • An Update to In Vitro Diagnostics Regulatory Requirements Worldwide
  • Medical Device Software: Current Developments in the Regulatory World
  • Medical Device Clinical Evaluation Reports (CERs) -What you need to know

Infographics

  • Medical Device Regulations

Related Services

  • GxP Services
  • Health Authority / Agency Interaction
  • MedTech Services
  • PAI Readiness
  • Quality Management Systems
  • Tech Transfer / Scale-up
  • Toxicology Services
  • Virtual Audits
Biopharma Excellence Website Image

PharmaLex Brings You Biopharma Excellence

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.

Visit Website
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
PharmaLexGLOBALPharmaLex@PharmaLexGLOBAL·
8 Jun

Mark A Lane, PhD latest blog here https://lnkd.in/ejDdywz3 explores Integrated Product Development approaches to accelerate drug development.

To find out more register for our IPD webinar https://lnkd.in/eijUBJM5

#pharmadrugdevelopment
#webinar
#biopharmaceutical

COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY
  • They are available when we need to talk to them despite any time zone differentials

    Japan based medium sized company
    Manager
PharmaLex
©2022 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit LogoSGS Logo

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

Many thanks for your understanding.

The PharmaLex Team

    Please DO NOT send us event/conference information.
    We will not respond and these will be deleted immediately.






    Select your state:

    .
    If you do not wish to receive any communication from us, you may unsubscribe at any time.

    #AskTheExpert #TogetherBEYONDCOVID19





      Select your state:

      .
      You can unsubscribe at any time at data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      #TogetherBEYONDCOVID19

      We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for